Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Publication year range
1.
Cir. Esp. (Ed. impr.) ; 101(3): 187-197, mar. 2023. ilus, tab
Article in Spanish | IBECS | ID: ibc-216905

ABSTRACT

Introducción: Durante los últimos años las técnicas de mastectomía y reconstrucción han evolucionado hacia procedimientos menos agresivos, mejorando la satisfacción y calidad de vida de la mujer. Por ello, la mastectomía se ha convertido en una opción válida tanto para mujeres con cáncer de mama como en mujeres de alto riesgo. El objetivo de este estudio es analizar la seguridad de la mastectomía y reconstrucción inmediata prepectoral con implante de poliuretano en mujeres con cáncer de mama y reducción de riesgo. Métodos: Estudio prospectivo observacional para evaluar la factibilidad y seguridad de la reconstrucción inmediata mediante implante prepectoral de poliuretano. Se incluyeron todas las mujeres (con cáncer de mama o alto riesgo para cáncer de mama) intervenidas mediante una mastectomía preservadora de piel o piel y pezón con reconstrucción inmediata con implante de poliuretano prepectoral. Se excluyeron las mujeres con sarcomas de mama, progresión de la enfermedad durante el tratamiento sistémico primario, reconstrucción diferida, autóloga o retropectoral y aquellas pacientes que no desearon participar en el estudio. Los procedimientos quirúrgicos fueron realizados tanto por cirujanos senior como junior. Todas las pacientes recibieron los tratamientos complementarios correspondientes. Se analizaron todos los eventos adversos acontecidos durante el seguimiento y los factores de riesgo para desarrollarlos. Resultados: Se realizaron 159 reconstrucciones en 102 mujeres, el 80,4% por un carcinoma mamario. Catorce pacientes desarrollaron complicaciones, siendo el seroma y la dehiscencia de la herida las más frecuentes. Ocho mujeres precisaron una reintervención (5%), 7 de ellas por exposición del implante. Cuatro reconstrucciones (2,5%) culminaron con pérdida del implante. Tres pacientes presentaron progresión de su proceso oncológico: una recaída local en el colgajo de la mastectomía, una progresión axilar y una progresión sistémica. (AU)


Introduction: In recent years, mastectomy and reconstruction techniques have evolved towards less aggressive procedures, improving the satisfaction and quality of life of women. For this reason, mastectomy has become a valid option for both women with breast cancer and high-risk women. The objective of this study is to analyze the safety of mastectomy and immediate prepectoral reconstruction with polyurethane implant in women with breast cancer and risk reduction. Method: Observational prospective study to evaluate the feasibility and safety of immediate reconstruction using prepectoral polyurethane implant. All women (with breast cancer or high risk for breast cancer) who underwent skin-sparing or skin-and-nipple-sparing mastectomy with immediate reconstruction with a prepectoral polyurethane implant were included. Women with breast sarcomas, disease progression during primary systemic therapy, delayed, autologous or retropectoral reconstruction, and those who did not wish to participate in the study were excluded. Surgical procedures were performed by both senior and junior surgeons. All patients received the corresponding complementary treatments. All adverse events that occurred during follow-up and the risk factors for developing them were analyzed. Results: 159 reconstructions were performed in 102 women, 80.4% due to breast carcinoma. Fourteen patients developed complications, the most frequent being seroma and wound dehiscence. Eight women required a reoperation (5.0%), seven of them due to implant exposure. Four reconstructions (2.5%) resulted in loss of the implant. Three patients progressed from their oncological process: a local relapse in the mastectomy flap, an axillary progression and a systemic progression. (AU)


Subject(s)
Humans , Female , Adult , Middle Aged , Aged , Breast Neoplasms/surgery , Polyurethanes , Mammaplasty/methods , Prospective Studies
2.
Cir Esp (Engl Ed) ; 101(3): 187-197, 2023 Mar.
Article in English | MEDLINE | ID: mdl-36108952

ABSTRACT

INTRODUCTION: In recent years, mastectomy and reconstruction techniques have evolved towards less aggressive procedures, improving the satisfaction and quality of life of women. For this reason, mastectomy has become a valid option for both women with breast cancer and high-risk women. The objective of this study is to analyze the safety of mastectomy and immediate prepectoral reconstruction with polyurethane implant in women with breast cancer and risk reduction. METHOD: Observational prospective study to evaluate the feasibility and safety of immediate reconstruction using prepectoral polyurethane implant. All women (with breast cancer or high risk for breast cancer) who underwent skin-sparing or skin-and-nipple-sparing mastectomy with immediate reconstruction with a prepectoral polyurethane implant were included. Women with breast sarcomas, disease progression during primary systemic therapy (PST), delayed, autologous or retropectoral reconstruction, and those who did not wish to participate in the study were excluded. Surgical procedures were performed by both senior and junior surgeons. All patients received the corresponding complementary treatments. All adverse events that occurred during follow-up and the risk factors for developing them were analyzed. RESULTS: 159 reconstructions were performed in 102 women, 80.4% due to breast carcinoma. Fourteen patients developed complications, the most frequent being seroma and wound dehiscence. Eight women required a reoperation (5.0%), seven of them due to implant exposure. Four reconstructions (2.5%) resulted in loss of the implant. Three patients progressed from their oncological process: a local relapse in the mastectomy flap, an axillary progression and a systemic progression. CONCLUSIONS: Prepectoral reconstruction with a polyurethane implant is a procedure with a low incidence of postoperative complications (8.8%) and implant loss (2.5%). Its use is safe with perioperative cancer treatments (neoadjuvant chemotherapy and radiotherapy).


Subject(s)
Breast Implants , Breast Neoplasms , Mammaplasty , Humans , Female , Mastectomy/methods , Breast Neoplasms/surgery , Prospective Studies , Polyurethanes , Quality of Life , Retrospective Studies , Neoplasm Recurrence, Local/surgery , Mammaplasty/methods , Breast Implants/adverse effects , Postoperative Complications/epidemiology
3.
PLoS One ; 17(7): e0269426, 2022.
Article in English | MEDLINE | ID: mdl-35834508

ABSTRACT

BACKGROUND: Mastectomy currently constitutes a necessary surgical procedure in the oncologic setting and in the context of high risk. Prepectoral breast reconstruction (PBR) has been proposed as a surgical alternative to retropectoral techniques by providing less postoperative morbidity and a better cosmetic result. However, there is a lack of prospective studies that have evaluated its safety and patient-reported satisfaction. METHODS: We conducted a prospective cohort study to assess the safety, quality of life and cosmetic sequelae of PBR in women with breast cancer and high risk. The study's main objective is to assess the safety of PBR in terms of postsurgical complications and the feasibility of reconstruction (loss of implants). The secondary objectives are to evaluate oncologic safety (local relapses, residual glandular tissue) and to identify factors related to quality of life and cosmetic sequelae. The evaluation of residual tissue will be conducted by MRI 12 to 18 months after the surgery, and the quality-of-life assessment will be performed using the Breast-Q questionnaire. An initial patient evaluation will be conducted 12-18 months after the surgery, and a second evaluation will be performed at 5 years. The estimated sample size is 81 patients. DISCUSSION: The PreQ-20 study will analyze the impact of PBR on 3 separate measures: safety, quality of life and cosmetic sequelae. Unlike other studies that analyzed these three measures jointly for women with breast cancer and high risk, this study will individualize the results for these 2 patient groups. This differentiation is necessary from the methodological point of view, given that the 2 patient groups have separate clinical and emotional implications. The assessment of these groups will focus on the following aspects: postoperative complications, local relapses, evaluation of residual glandular tissue and incidence rate of primary tumors in the same, the cosmetic sequelae and the satisfaction and the quality-of-life assessment by the patients. TRIAL REGISTRATION: ClinicalTrials.gov: NCT04642508.


Subject(s)
Breast Neoplasms , Mammaplasty , Breast Implants , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Female , Humans , Mammaplasty/adverse effects , Mammaplasty/methods , Mastectomy , Neoplasm Recurrence, Local/surgery , Patient Satisfaction , Prospective Studies , Quality of Life
4.
Rev. senol. patol. mamar. (Ed. impr.) ; 35(2): 134-136, Abril - Junio 2022. ilus
Article in Spanish | IBECS | ID: ibc-230666

ABSTRACT

El carcinoma mioepitelial de la mama es un tumor infrecuente, con pocos casos descritos en la literatura, por lo que su diagnóstico es difícil y su tratamiento un desafío que incluye el diseño de colgajos locales. Presentamos un caso clínico de carcinoma mioepitelial de mama con progresión locorregional tras quimioterapia y radioterapia, así como una revisión de la literatura que nos permiten establecer un diagnóstico definitivo y un tratamiento óptimo oncológico y quirúrgico con reconstrucción de este tumor.(AU)


Myoepithelial carcinoma of the breast is an uncommon tumour with few cases reported in the literature. Consequently, it is a diagnostic and therapeutic challenge. Treatment includes the design of local flaps. We present a case of myoepithelial carcinoma of the breast with locoregional progression after chemotherapy and radiotherapy. We also provide a review of the literature, allowing us to establish a definitive diagnosis and optimal oncological and surgical treatment with reconstruction of this tumour.(AU)


Subject(s)
Humans , Female , Breast Neoplasms , Myoepithelioma/diagnosis , Myoepithelioma/surgery , Myoepithelioma/therapy , Review Literature as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...